The FDA has approved an expanded indication for the CD3-directed monoclonal antibody teplizumab-mzwv to delay stage 3 type 1 ...
New analysis from London Medical Laboratory has revealed up to 18 million UK adults could have prediabetes – which means they are on the verge of developing type 2 diabetes. That’s considerably higher ...
A new analysis suggests having diabetes may significantly increase a person's risk of MS, though no evidence was found a ...
An analysis of patient-reported outcomes (PROs) from the SURPASS-SWITCH trial found that adults with type 2 diabetes who switched from dulaglutide to tirzepatide not only saw stronger improvements in ...
Read more about the mechanisms underlying the near fourfold higher risk of frozen shoulder in patients with diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results